Skip to content

Clinical trials

Mucopolysaccharidosis III trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20141
20151
20172
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LYSOGENE3
Abeona Therapeutics, Inc2
Shire2
Institut National de la Santé Et de la Recherche Médicale, France1
Phoenix Nest1
UniQure Biopharma B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III10
Genetic Diseases, Inborn2
Lysosomal Storage Diseases2
Metabolic Diseases2
Mucopolysaccharidosis II2
Neurodegenerative Diseases2
Mucopolysaccharidoses1
Mucopolysaccharidosis I1
Mucopolysaccharidosis IV1
Mucopolysaccharidosis VI1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.